These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37064559)

  • 1. Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions.
    Li L; Tong Z; Cui S; Guo L
    Wideochir Inne Tech Maloinwazyjne; 2023 Mar; 18(1):166-172. PubMed ID: 37064559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S; Kokkinidis DG; Jawaid O; Behan S; Hossain P; Alvandi B; Foley TR; Singh GD; Waldo SW; Armstrong EJ
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions.
    Zhang B; Niu G; Yan Z; Zou Y; Tong X; Yang M
    Front Surg; 2020; 7():616414. PubMed ID: 33521048
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes and Comparative Analysis of the Initial Results of Standard Balloon Angioplasty Versus Drug-Coated Balloons Alone Versus in Association With Laser-Excimer Atherectomy in the Treatment of Femoropopliteal Artery In-Stent Restenosis (INTACT).
    Ducasse E; Sapoval M; Brunet J; Commeau P; Goueffic Y; Sabatier J; Steinmetz E; Lermusiaux P; Rosset E; Caradu C
    J Endovasc Ther; 2024 Apr; ():15266028241248333. PubMed ID: 38659343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Mechanical Atherectomy Plus Thrombectomy Using the Rotarex®S Device Followed by a Drug-Coated Balloon for the Treatment of Femoropopliteal Artery In-stent Restenosis: A Prospective Single-Center, Single-Arm Efficacy Trial (PERMIT-ISR Trial).
    Liu MY; Li W; Guo X; Zhang Z; Liu B; Yu H; Zhang Z; Chen X; Feng H
    Front Surg; 2021; 8():671849. PubMed ID: 34595204
    [No Abstract]   [Full Text] [Related]  

  • 8. A systematic review and meta-analysis of the efficacy of debulking devices for in-stent restenosis of the femoropopliteal artery.
    Li X; Zhou M; Ding Y; Wang Y; Cai L; Shi Z
    J Vasc Surg; 2020 Jul; 72(1):356-366.e5. PubMed ID: 32093910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of recurrence after paclitaxel drug-coated balloon use for treating femoropopliteal in-stent restenosis.
    Taha AG; Saleh MI; Ali H; Gamal WM
    Vascular; 2024 Aug; 32(4):834-841. PubMed ID: 36896828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis.
    He Z; Wang H; Lin F; Ding W; Chen K; Zhang Z
    Vasc Med; 2022 Jun; 27(3):239-250. PubMed ID: 35164613
    [No Abstract]   [Full Text] [Related]  

  • 12. Stent Graft vs Drug-Coated Balloon in Endovascular Treatment of Complex Femoropopliteal Artery Lesions: A 2-Center Experience.
    Ye M; Ni Q; Zhu Y; Du Y; Wang Y; Guo X; Zhang L; Feng Z
    J Endovasc Ther; 2023 Sep; ():15266028231201097. PubMed ID: 37728023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stand-Alone Rotational Atherectomy Versus Combination With Drug-Coated Balloon Angioplasty for the Endovascular Treatment of Heavily-Calcified Femoropopliteal and Popliteal Lesions.
    Kronlage M; Bertele M; Linden F; Frey N; Erbel C
    J Endovasc Ther; 2023 Dec; ():15266028231219663. PubMed ID: 38146867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review and Meta-analysis of Atherectomy Plus Balloon Angioplasty Versus Balloon Angioplasty Alone for Infrapopliteal Arterial Disease.
    Wu H; Zheng D; Zhou L; Wang Q; Wang T; Liang S
    J Endovasc Ther; 2023 Nov; ():15266028231209236. PubMed ID: 37933456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Coated Balloon Angioplasty for Femoropopliteal In-Stent Restenosis.
    Cassese S; Wolf F; Ingwersen M; Kinstner CM; Fusaro M; Ndrepepa G; Ibrahim T; Ott I; Lammer J; Krankenberg H; Fusaro M
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007055. PubMed ID: 30562083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM; Hyder ON; Soukas PA
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role for DCBs in the treatment of ISR.
    Bague N; Nasr B; Chaillou P; Costargent A; Gouailler-Vulcain F; Goueffic Y
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):578-85. PubMed ID: 27102629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW; Shammas GA; Jones-Miller S; Shammas WJ; Bou-Dargham B; Shammas AN; Banerjee S; Rachwan RJ; Daher GE
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis.
    Tong Z; Guo L; Qi L; Cui S; Gao X; Li Y; Guo J; Gu Y
    Biomed Res Int; 2020; 2020():3076346. PubMed ID: 32596293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mid- and long-term outcomes and prognostic factors of drug-coated balloon angioplasty for treatment of femoropopliteal long lesions].
    Cao ZJ; Zhang T; Zhao KQ; Zhao JL; Yu XH; Li YW; Wu WW
    Zhonghua Wai Ke Za Zhi; 2022 Jan; 60(1):57-62. PubMed ID: 34954948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.